<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>Insight数据库 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-17T20:30:48+08:00</updated>
  <subtitle>丁香园 Insight 数据库（db.dxy.cn），拥有申报、临床、上市、药企等 10 大核心数据。致力于分享医药行业政策解读、药企大事和药品申报情报等</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>这 43 个新药，获批临床了</title>
    <updated>2020-11-17T18:01:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/zqb0nhGRMUgqIu_Pl0clsQ</id>
    <link href="https://mp.weixin.qq.com/s/zqb0nhGRMUgqIu_Pl0clsQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>Insight 策划 | 生物药研发策略沙龙下周二苏州见！</title>
    <updated>2020-11-17T18:01:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/pNnPqVTUuDpF1mkGyPRIIw</id>
    <link href="https://mp.weixin.qq.com/s/pNnPqVTUuDpF1mkGyPRIIw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>10 亿重磅注射剂！华东医药「注射用泮托拉唑钠」过评</title>
    <updated>2020-11-17T18:01:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/v7A2w48CYzxuPXEdR8RnJQ</id>
    <link href="https://mp.weixin.qq.com/s/v7A2w48CYzxuPXEdR8RnJQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞 CDK4/6 抑制剂获批临床</title>
    <updated>2020-11-17T18:01:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/SVq9UTfLEsXurtzvLn1RqQ</id>
    <link href="https://mp.weixin.qq.com/s/SVq9UTfLEsXurtzvLn1RqQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>94.5% 有效率！Moderna 公司 mRNA 新冠疫苗新进展</title>
    <updated>2020-11-17T18:01:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/gU_gYLYi-HlihBPBXzz2Ag</id>
    <link href="https://mp.weixin.qq.com/s/gU_gYLYi-HlihBPBXzz2Ag" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>先声药业 SIM1803-1A 启动临床</title>
    <updated>2020-11-17T18:01:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/P6CsVMvE6V6AAeGxliQyeQ</id>
    <link href="https://mp.weixin.qq.com/s/P6CsVMvE6V6AAeGxliQyeQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药企授权交易频繁，国内药企研发实力日益获得国际认可</title>
    <updated>2020-11-16T17:57:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/Dw4QVojibUf38U_EdiE9pg</id>
    <link href="https://mp.weixin.qq.com/s/Dw4QVojibUf38U_EdiE9pg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>百济神州 HER2 双抗今日获批临床，拟于 2021 上半年登陆科创板，首家三地上市</title>
    <updated>2020-11-16T17:57:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/vNtzv52Lcwh_4bca8-h8zQ</id>
    <link href="https://mp.weixin.qq.com/s/vNtzv52Lcwh_4bca8-h8zQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>恒瑞 SHR-1314 单抗获批临床</title>
    <updated>2020-11-16T17:57:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/fSziEPF8_9bXzj7NyJNtUg</id>
    <link href="https://mp.weixin.qq.com/s/fSziEPF8_9bXzj7NyJNtUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【本周四】2020药品上市许可持有人（MAH）政策解读与生产许可证申请实施培训</title>
    <updated>2020-11-16T17:57:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/xyqeS1M11lUN7Xo2ZMIkUA</id>
    <link href="https://mp.weixin.qq.com/s/xyqeS1M11lUN7Xo2ZMIkUA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 年 10 月 CDE 药品审评报告</title>
    <updated>2020-11-14T12:00:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-14:/s/qyOpE3xIdzaBRh_s7qSFQg</id>
    <link href="https://mp.weixin.qq.com/s/qyOpE3xIdzaBRh_s7qSFQg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>君实电话会议：拓益临床口碑良好，正积极备战医保谈判！</title>
    <updated>2020-11-13T18:06:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/tl4L7z1nYE4gyjfMgusTxw</id>
    <link href="https://mp.weixin.qq.com/s/tl4L7z1nYE4gyjfMgusTxw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>重磅乙肝药「丙酚替诺福韦」又有一家获批</title>
    <updated>2020-11-13T18:06:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/2pzR6iWNjpLHX3FBV9e4uA</id>
    <link href="https://mp.weixin.qq.com/s/2pzR6iWNjpLHX3FBV9e4uA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>正大天晴「泊马度胺胶囊」首仿获批</title>
    <updated>2020-11-13T18:06:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/2L3kqhEVnnXcIuZ8JmEmFg</id>
    <link href="https://mp.weixin.qq.com/s/2L3kqhEVnnXcIuZ8JmEmFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二款国产 PD-L1 单抗上市申请获受理</title>
    <updated>2020-11-13T18:06:03+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-13:/s/xRol23Niw0d281AvqN8xEQ</id>
    <link href="https://mp.weixin.qq.com/s/xRol23Niw0d281AvqN8xEQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>复星医药新冠 mRNA 疫苗 BNT162b2 临床申请获受理</title>
    <updated>2020-11-12T10:05:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-12:/s/qTWSvC_Szo8YCYSVMko-Bw</id>
    <link href="https://mp.weixin.qq.com/s/qTWSvC_Szo8YCYSVMko-Bw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>年销售近 20 亿！科伦药业「丙泊酚中/长链脂肪乳注射液」获批</title>
    <updated>2020-11-11T16:56:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/JM10WeXT7zG__7ekLWLi7g</id>
    <link href="https://mp.weixin.qq.com/s/JM10WeXT7zG__7ekLWLi7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第二个 1 类新药！贝达药业「恩莎替尼」即将获批</title>
    <updated>2020-11-11T16:56:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/ufQPhQ6_cGJE7S4N_Q1yHw</id>
    <link href="https://mp.weixin.qq.com/s/ufQPhQ6_cGJE7S4N_Q1yHw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CD47 单抗信达生物领跑，国内还有这些企业在布局</title>
    <updated>2020-11-11T16:56:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/1kMOtNAgoAAc3SBCixCMPQ</id>
    <link href="https://mp.weixin.qq.com/s/1kMOtNAgoAAc3SBCixCMPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2020 新医保初审结果出炉，即将开始谈判</title>
    <updated>2020-11-11T16:56:37+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-11:/s/z2D5gFPg--4En97YsY7SPQ</id>
    <link href="https://mp.weixin.qq.com/s/z2D5gFPg--4En97YsY7SPQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>